Pooled responder rates for those patients who completed titration and were evaluated on a stable dose (evaluation period), and for all patients randomised (the intent to treat population) during the complete treatment period
| Evaluation period on stable dose | Intent to treat population, total treatment period titration included | |||||||
|---|---|---|---|---|---|---|---|---|
| Levetiracetam | Levetiracetam | |||||||
| Placebo (n=301) | 1000 mg/day (n=195) | 2000 mg/day (n=95) | 3000 mg/day (n=269) | Placebo (n=312) | 1000 mg/day (n=204) | 2000 mg/day (n=106) | 3000 mg/day (n=282) | |
| *Seizure-free during the analysed period (evaluation period or total treatment period). | ||||||||
| ≥50% responder rate | 12.6 | 27.7 | 31.6 | 41.3 | 9.4 | 28.6 | 35.2 | 39.5 |
| ≥75% responder rate | 3.3 | 11.8 | 16.8 | 22.3 | 2.6 | 10.8 | 16.2 | 22.4 |
| Seizure freedom* | 0.6 | 3.9 | 2.1 | 8.2 | 0.3 | 2.9 | 2.8 | 6.0 |